Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Statement regarding change in majority of directors pursuant to Rule 14f-1

SC 14F1
3,4,5
KNIGHT ROBERT 0001022871-00-500001.pdf 0001022871-00-500001.rtf 0001022871-00-500001.xls View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
0001103021-00-500006.pdf 0001103021-00-500006.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-00-500004.pdf 0001103021-00-500004.rtf 0001103021-00-500004.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
TSAI AARON 0001082990-00-000124.pdf 0001082990-00-000124.rtf 0001082990-00-000124.xls View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
TSAI AARON 0001082990-00-000122.pdf 0001082990-00-000122.rtf View HTML

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0001103021-00-000008.pdf 0001103021-00-000008.rtf 0001103021-00-000008.xls View HTML

An amendment to a previously filed 10QSB

10QSB/A
Quarterly Filings
0001103021-00-000007.pdf 0001103021-00-000007.rtf 0001103021-00-000007.xls View HTML

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0001103021-00-000005.pdf 0001103021-00-000005.rtf 0001103021-00-000005.xls View HTML

Withdrawal of registration statement filed under the Securities Act

RW
Other
0001103021-00-000004.pdf 0001103021-00-000004.rtf View HTML

Optional form for the registration of securities to be sold to the public by small business issuers

SB-2
Registration Statements
0001103021-00-000003.pdf 0001103021-00-000003.rtf 0001103021-00-000003.xls View HTML

Copyright Morningstar